Response Biomedical's Q1 Sales Bounce 50 Percent | GenomeWeb

NEW YORK (GenomeWeb News) – Response Biomedical today reported that product sales for the first quarter rose 50 percent year over year on the strength of its cardiovascular tests.

The Vancouver, British Columbia-based firm recorded product sales of C$3 million (US$3 million) for the three months ended March 31, up from $2 million a year ago, as cardiovascular sales increased 80 percent year over year to $2.7 million from $1.5 million. Improved performance in China was the primary driver of growth in the cardiovascular business, Response Biomedical said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Harold Varmus, a former NIH director, says that proposed reductions to the agency's budget are worrisome.

The Genome 10K project is to sequence about 10,000 vertebrate genomes, including ones of endangered species, Digital Trends reports.

The new Coalition to Save NIH Funding aims to educate lawmakers and the public on the significance of biomedical research.

In PLOS this week: analysis of viral sequences from human blood samples, gut microbiomes of heart failure patients, and more.